Coarse facies, calvarial thickening and hyperphosphatasia associated with long-term anticonvulsant therapy.
D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood*; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D003975:Diazepam / Q000009:adverse effects; D005013:Ethosuximide / Q000009:adverse effects; D005149:Facial Expression; D005885:Gingival Hyperplasia / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011324:Primidone / Q000009:adverse effects; D012886:Skull / Q000187:drug effects*; D013997:Time Factors
D000927:Anticonvulsants; D011324:Primidone; D005013:Ethosuximide; D010672:Phenytoin; D000469:Alkaline Phosphatase; D003975:Diazepam; D010634:Phenobarbital